Flosulide

Drug Profile

Flosulide

Alternative Names: CGP 28238; CGS 28238; SH 459; ZK 38997

Latest Information Update: 03 Sep 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer Schering Pharma
  • Developer Imperial Innovations
  • Class Antirheumatics; Indans; Nonsteroidal anti-inflammatories; Small molecules
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Preterm labour; Rheumatic disorders

Most Recent Events

  • 19 Oct 1999 Preclinical development for Preterm labour in United Kingdom (Unknown route)
  • 15 Sep 1997 Investigation in Rheumatic disorders (PO)
  • 12 Sep 1997 A study in patients with osteoarthritis has been added to the adverse events section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top